Trials / Completed
CompletedNCT02603770
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
A Single Site, Randomized Open Label Cross-Over Study to Compare Pharmacokinetic Profiles (PK) of XueZhiKang (XZK) Capsules Versus Lovastatin Tablets in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Luye Pharma Group Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to compare laboratory tests profiles of a botanic drug XueZhiKang (XZK) 300 mg capsules versus a marketed drug Lovastatin 20 mg tablets in healthy male volunteers between 18 and 50 years of age.
Detailed description
Twenty (20) healthy male subjects will be enrolled and assigned to either XZK group or Lovastatin group at a 1:1 ratio at one site in the USA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | XueZhiKang | |
| DRUG | Lovastatin |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-01-01
- Completion
- 2016-02-01
- First posted
- 2015-11-13
- Last updated
- 2016-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02603770. Inclusion in this directory is not an endorsement.